Tissue Regenix Group (LON:TRX) Shares Cross Above 50 Day Moving Average – Should You Sell?

by · The Cerbat Gem

Shares of Tissue Regenix Group plc (LON:TRX – Get Free Report) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 58.20 ($0.73) and traded as high as GBX 60 ($0.75). Tissue Regenix Group shares last traded at GBX 60 ($0.75), with a volume of 12,966 shares changing hands.

Tissue Regenix Group Trading Up 3.4 %

The company has a current ratio of 3.74, a quick ratio of 2.36 and a debt-to-equity ratio of 35.69. The company has a 50 day simple moving average of GBX 58.33 and a 200 day simple moving average of GBX 60.75. The stock has a market capitalization of £42.74 million, a PE ratio of -6,000.00 and a beta of 1.61.

About Tissue Regenix Group

(Get Free Report)

Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.

Read More